Clinical Scorecard: Transperineal Biopsy Targeting of Prostate Tumors Shows Minimal Added Value Compared to Standard Background Cores for Larger MRI-Detected Lesions

At a Glance

Key Highlights

• Transperineal biopsy offers advantages over transrectal approach including reduced sepsis and better sampling of anterior/apical tumors.
• MRI-targeted biopsies improve detection of clinically significant prostate cancer and reduce detection of insignificant tumors.
• Additional targeted cores may have minimal added value for larger MRI-detected lesions compared to systematic background sector biopsies.

Guideline-Based Recommendations

Diagnosis

• Use multi-parametric MRI (mp-MRI) to detect and localize prostate tumors prior to biopsy.
• Define positive MRI targets as Likert score 4 or 5 for biopsy targeting.
• Perform MRI-TRUS fusion transperineal biopsy with systematic background sector cores plus targeted cores.

Management

• Limit total biopsy cores to minimize morbidity and procedural time while ensuring adequate tumor detection.
• Balance number of targeted cores with systematic cores to optimize diagnostic yield and reduce complications.
• Consider transperineal approach to reduce infection risk and improve sampling of difficult tumor locations.

Monitoring & Follow-up

• Monitor biopsy outcomes including cancer detection rates, maximum cancer core length, and grade stratification.
• Assess MRI quality and radiologist experience to reduce false-negative rates.
• Track biopsy-related morbidity and complications, especially with increased core numbers.

Risks

• Increased biopsy cores may increase morbidity and complicate subsequent surgery.
• General anesthesia requirement for transperineal biopsy may limit accessibility and capacity.
• False-negative MRI results necessitate systematic background sampling to avoid missed tumors.

Patient & Prescribing Data

Patients with high-probability MRI-detected prostate lesions undergoing biopsy

Targeted biopsy cores improve detection of clinically significant cancer but may offer minimal additional benefit over systematic cores for larger lesions; minimizing cores reduces morbidity.

Clinical Best Practices

• Perform mp-MRI with standardized protocols and experienced radiologist interpretation using PI-RADS or Likert scoring.
• Use MRI-TRUS fusion platforms for precise transperineal biopsy targeting.
• Obtain systematic background sector biopsies in addition to targeted cores to mitigate MRI false negatives.
• Limit biopsy cores to the minimum necessary to detect index lesions and reduce patient morbidity.
• Prefer transperineal approach for improved safety and sampling of anterior/apical prostate regions.

References

• START standards for MRI-targeted prostate biopsy studies
• Ginsburg study group recommendations on MRI-guided transperineal biopsy
• PI-RADS prostate imaging-reporting and data system